3rd Party Ad. Not an offer or recommendation by Stocktwits. See disclosure here or
3rd Party Ad. Not an offer or recommendation by Stocktwits. See disclosure here or
3rd Party Ad. Not an offer or recommendation by Stocktwits. See disclosure here or
| Watchers | 526 |
| 52-Wk Low | $24.31 |
| 52-Wk High | $64.98 |
| Market Cap | $2.67B |
| Volume | 37,355.00 |
| 52-Wk High | $64.98 |
| 52-Wk Low | $24.31 |
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. MoonLake Immunotherapeutics - Ordinary Shares - Class A market cap is $2.67B.
52 week high is the highest price of a stock in the past 52 weeks, or one year. MoonLake Immunotherapeutics - Ordinary Shares - Class A 52 week high is $64.98 as of June 07, 2024.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. MoonLake Immunotherapeutics - Ordinary Shares - Class A 52 week low is $24.31 as of June 07, 2024.
MoonLake Immunotherapeutics - Ordinary Shares - Class A stock price today is $42.00.
MoonLake Immunotherapeutics - Ordinary Shares - Class A stock price yesterday was $42.44.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. MoonLake Immunotherapeutics - Ordinary Shares - Class A’s P/E ratio is -56.55.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. MoonLake Immunotherapeutics - Ordinary Shares - Class A P/B ratio is 4.9182.
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. MoonLake Immunotherapeutics - Ordinary Shares - Class A's EBITDA is -42.85.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. MoonLake Immunotherapeutics - Ordinary Shares - Class A 50-day moving average is $43.05.
MoonLake Immunotherapeutics - Ordinary Shares - Class A has 50 employees.